BioCentury
ARTICLE | Company News

Aphton, Celltrion deal

August 1, 2005 7:00 AM UTC

APHT's Igeneon subsidiary (Vienna, Austria) granted Celltrion commercialization rights to IGN311 in certain Asian countries, including Japan. The monoclonal antibody targeting the Lewis Y antigen is ...